| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |